Partenaires

Centre National de la recherche scientifique
Logo de l'université de Toulouse Logo de l'Universite Paul Sabatier
Fédération de recherche en biologie de Toulouse



Search

On this website

On the whole CNRS Web


The research at IPBS

The primary objective of the Institute of Pharmacology and Structural Biology, headed by Jean Philippe GIRARD, is the identification and characterization of novel pharmacological targets in the fields of Cancer and Infectious Diseases (Tuberculosis).

The technology portfolio

News All news

16 July 2015

Identification of a critical actor controlling trafficking of leukemia cells

Chronic lymphocytic leukemia (CLL) is the most common leukemia in (...) Read more

28 May 2015

Opportunities for Junior group leaders

We are currently seeking new junior group leaders in the fields of (...) Read more


Seminars

Seminars

- GE Healthcare Life Sciences: DeltaVisionTM Elite: Microscopie à haute résolution, haute sensibilité et haute vitesse

Seminar : Tuesday, Sept 22, from 10:30 am to 11:30 am - Seminars room
Demonstration : Tuesday, Sept 22, afternoon to Thursday, Sept 24 morning

Read more

To be noted

2nd Toulouse Conference in Integrated Structural Biology

The 2nd Toulouse Conference in Integrated Structural Biology will be held on Monday 5 October (...)

Press Releases

15 July 2015

Identification of a critical actor controlling trafficking of leukemia cells

Chronic lymphocytic leukemia (CLL) is the most common leukemia in (...)

Read more

22 April 2015

Teamwork in the cell: the spatial synchrony of podosomes

Podosomes are used by immune cells to probe and deform their (...)

Read more

12 February 2015

HIV reprograms the migration of human macrophages: a potential way to disseminate in the body

The team headed by Isabelle Maridonneau-Parini at the Institute of (...)

Read more

9 November 2014

How macrophages probe their environment ?

Macrophages are immune cells capable of migrating through all body (...)

Read more

14 October 2014

Key step in allergic reactions revealed

By studying the mode of action of the interleukin-33 protein, an (...)

Read more